SEC Form 4 · accession 0001232524-17-000082
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen J Wilson
Officer — SVP, Finance & PAO
Period of report
Apr 10, 2017
Accepted (ET)
Apr 11, 2017 · 8:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Apr 10, 2017 | M | 4,750 | $59.13 | A | 27,158 | D | |
| Ordinary Shares | Apr 10, 2017 | S | 4,750 | $152.24 | D | 22,408 | D | |
| Ordinary Shares | Apr 10, 2017 | M | 6,708 | $46.83 | A | 29,116 | D | |
| Ordinary Shares | Apr 10, 2017 | S | 6,708 | $152.24 | D | 22,408 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $46.83 | Apr 10, 2017 | M | 6,708 | D | — | Aug 8, 2022 | Ordinary Shares | 6,708 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $59.13 | Apr 10, 2017 | M | 4,750 | D | — | Mar 4, 2023 | Ordinary Shares | 4,750 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2This non-qualified stock option is part of an option granted on August 9, 2012 that consisted of an incentive stock option exercisable for 3,048 ordinary shares and this non-qualified stock option exercisable for 26,952 ordinary shares. The options were fully vested as of August 9, 2016.
- F3This non-qualified stock option is part of an option granted on March 5, 2013 that consisted of an incentive stock option exercisable for 750 ordinary shares and this non-qualified stock option exercisable for 11,250 ordinary shares. The options were fully vested as of March 5, 2017.